A detailed history of Regent Investment Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Regent Investment Management LLC holds 95,901 shares of BMY stock, worth $5.65 Million. This represents 1.85% of its overall portfolio holdings.

Number of Shares
95,901
Previous 97,011 1.14%
Holding current value
$5.65 Million
Previous $6.9 Million 0.07%
% of portfolio
1.85%
Previous 2.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 26, 2023

SELL
$68.48 - $81.09 $76,012 - $90,009
-1,110 Reduced 1.14%
95,901 $6.9 Million
Q3 2022

Oct 18, 2022

BUY
$0.13 - $76.84 $67 - $39,956
520 Added 0.54%
97,011 $6.9 Million
Q2 2022

Jul 15, 2022

SELL
$72.62 - $79.98 $74,798 - $82,379
-1,030 Reduced 1.06%
96,491 $7.43 Million
Q1 2022

Apr 19, 2022

SELL
$61.48 - $73.72 $47,032 - $56,395
-765 Reduced 0.78%
97,521 $7.12 Million
Q4 2021

Jan 27, 2022

SELL
$53.63 - $62.52 $211,034 - $246,016
-3,935 Reduced 3.85%
98,286 $6.13 Million
Q3 2021

Oct 21, 2021

BUY
$59.17 - $69.31 $64,791 - $75,894
1,095 Added 1.08%
102,221 $6.05 Million
Q2 2021

Jul 16, 2021

BUY
$61.91 - $67.42 $107,413 - $116,973
1,735 Added 1.75%
101,126 $6.76 Million
Q1 2021

Apr 20, 2021

BUY
$59.34 - $66.74 $143,899 - $161,844
2,425 Added 2.5%
99,391 $6.28 Million
Q4 2020

Jan 27, 2021

SELL
$57.74 - $65.43 $162,826 - $184,512
-2,820 Reduced 2.83%
96,966 $6.02 Million
Q3 2020

Oct 19, 2020

BUY
$57.43 - $63.64 $93,898 - $104,051
1,635 Added 1.67%
99,786 $6.02 Million
Q2 2020

Jul 29, 2020

BUY
$54.82 - $64.09 $469,259 - $548,610
8,560 Added 9.55%
98,151 $5.77 Million
Q1 2020

Apr 17, 2020

BUY
$46.4 - $67.43 $464,232 - $674,637
10,005 Added 12.57%
89,591 $4.99 Million
Q4 2019

Jan 30, 2020

BUY
$49.21 - $64.19 $3.05 Million - $3.98 Million
62,034 Added 353.43%
79,586 $5.11 Million
Q3 2019

Oct 17, 2019

SELL
$42.77 - $50.71 $12,831 - $15,213
-300 Reduced 1.68%
17,552 $890,000
Q1 2019

Apr 22, 2019

SELL
$45.12 - $53.8 $12,408 - $14,795
-275 Reduced 1.52%
17,852 $852,000
Q2 2018

Jul 16, 2018

SELL
$50.53 - $62.98 $551,787 - $687,741
-10,920 Reduced 37.59%
18,127 $1 Million
Q1 2018

Apr 24, 2018

BUY
$59.92 - $68.98 $227,396 - $261,779
3,795 Added 15.03%
29,047 $1.84 Million
Q4 2017

Jan 26, 2018

BUY
$59.94 - $65.35 $540,958 - $589,783
9,025 Added 55.62%
25,252 $1.55 Million
Q3 2017

Oct 12, 2017

BUY
$55.23 - $63.74 $896,217 - $1.03 Million
16,227
16,227 $1.03 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Regent Investment Management LLC Portfolio

Follow Regent Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Regent Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regent Investment Management LLC with notifications on news.